First patients to receive new experimental cancer pill
NCT ID NCT06804824
Summary
This is the first study in people to test a new oral drug called VVD-159642, which is designed to block specific cancer growth signals. It will enroll about 220 adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and get an early look at whether it can help shrink or control tumors, both when given alone and when combined with other cancer drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research South Australia (CRSA)
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Linear Clinical
RECRUITINGNedlands, Western Australia, 6009, Australia
-
NEXT Austin
RECRUITINGAustin, Texas, 78758, United States
-
NEXT Dallas
RECRUITINGIrving, Texas, 75039, United States
-
NEXT San Antonio
RECRUITINGSan Antonio, Texas, 78299, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
START Mid West
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain
RECRUITINGOgden, Utah, 84401, United States
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.